
AstraZeneca's Datroway receives FDA approval, Rio Tinto announces Hancock Prospecting JV
STOCKS TO WATCH Drugmaker AstraZeneca's Datroway has been approved in the US for patients with previously treated advanced EGFR-mutated non-small cell lung cancer. AstraZeneca said the indication was approved under accelerated approval based on …